GlassScriptPhysician profile
Heather D Stehr
NPI 1538884937
$557.44
in general payments reported to CMS, 2019-2025
20 companies · $48.50 in 2025
The $48.50 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.50 · 2023: $181 · 2024: $288 · 2025: $48.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $112.86 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $37.80 | 2023 | Verquvo, Dificid, Steglatro |
| Exact Sciences Corporation | $37.52 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $33.74 | 2022-2024 | Gattex |
| Harmony Biosciences LLC | $30.97 | 2024 | |
| Dexcom, INC. | $30.25 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $27.54 | 2023-2024 | |
| Radius Health, INC. | $26.65 | 2024 | Tymlos |
| Teleflex LLC | $25.75 | 2023 | Urolift |
| Daiichi Sankyo INC. | $25.45 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $23.99 | 2024 | Opsumit, Uptravi |
| Medtronic, INC. | $19.23 | 2025 | Inceptiv |
| Xeris Pharmaceuticals, INC. | $18.56 | 2024 | Keveyis |
| Novartis Pharmaceuticals Corporation | $17.04 | 2024 | |
| Abbvie INC. | $15.80 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.68 | 2024 | Bexsero, Shingrix, Arexvy |
| Corium, LLC | $15.53 | 2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $14.82 | 2023 | Ajovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.40 | 2023 | |
| Viatris Specialty LLC | $13.86 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Stehr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.